[{"Assets_0_FY_USD":"1404600000.0","CIK":"899923","CommonStockSharesConverted_0_FY_shares":"74700000.0","CommonStockSharesOutstanding_0_FY_shares":"74700000.0","Country":"United States","EarningsPerShareBasic_1_FY_USD":"-0.74","EarningsPerShareBasic_4_FY_USD":"-2.69","EarningsPerShareDiluted_1_FY_USD":"-0.74","EarningsPerShareDiluted_4_FY_USD":"-2.69","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":"60700000.0","NetIncomeLoss_1_FY_USD":"-55400000.0","NetIncomeLoss_4_FY_USD":"-199500000.0","OfficialName":"Myriad Genetics Inc. Common Stock","ProfitLoss_1_FY_USD":"-55500000.0","ProfitLoss_4_FY_USD":"-199600000.0","RevenuesConverted_1_FY_USD":"93200000.0","RevenuesConverted_4_FY_USD":"638600000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_FY_USD":"918200000.0","StockholdersEquity_0_FY_USD":"918200000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":"74.6","WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":"74300000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":"74.6","WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":"74300000.0","filed":"20200813","footnote":null,"form":"10-K","fp":"FY","fy":"2020.0","name":"MYRIAD GENETICS INC","period":"20200630","qtrs":"4","uom":"USD"}]